The Searle Company Limited has filed an IPO in the amount of PKR 4.544734 billion.

The Searle Company Limited is a Pakistan-based company, which is engaged in the manufacture of pharmaceuticals and other consumer products. The Company’s product categories include pharmaceutical, biopharmaceutical, nutraceutical, nutrition, consumer, and medical devices and disposables. The Company's product portfolio in the pharmaceutical range includes therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, central nervous system (CNS), ortho care, neuropsychiatry, probiotics, antibiotics, and nutritional care. Its pharmaceutical products include Analgesic & Muscle-Relaxant, Anti-Allergy & Anti-Tussive, Anti-Anemic, Anti-Chelating, Anti-infective, Anti-Neoplastic, Anti-Thrombotic, Cardiovascular, Endocrinology & Metabolism. It also focuses on specialty generic branded portfolios and targeting differentiated products. Its subsidiaries include IBL HealthCare Limited, Searle Pharmaceuticals (Private) Limited, and others.